Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec 14;7(1):337.
doi: 10.5195/cajgh.2018.337. eCollection 2018.

Discovery of Actinomycetes from Extreme Environments with Potential to Produce Novel Antibiotics

Affiliations

Discovery of Actinomycetes from Extreme Environments with Potential to Produce Novel Antibiotics

Lyudmila Trenozhnikova et al. Cent Asian J Glob Health. .

Abstract

Introduction: Antimicrobial-resistant pathogens pose serious challenges to healthcare institutions and health of the public. Thus, there is an urgent need for the discovery of new and effective antimicrobial agents. Microorganisms that exist in extreme environments such as those with high salinity or alkalinity, are known as extremophiles, and include various species of actinomycetes. The goal of this study is to discover novel antibiotics from extremophiles found in Kazakhstan that are effective against drug resistant pathogens.

Methods: Soil from extreme environments of Kazakhstan was collected, and pure cultures of actinomycetes were isolated and cultured in modified Bennett's broth with either high concentrations of salt or high pH to mimic extreme environments. Extracts obtained from selected actinomycetes strains were used to test for antimicrobial activity against Staphylococcus aureus, Escherichia coli and Aspergillus niger.

Results: A total of 5936 strains of extremophile actinomycetes were isolated; from these, 2019 strains were further isolated into pure cultures. Of these, 415 actinomycetes strains that demonstrated antagonistic antibacterial activities were selected. These actinomycetes were further classified into groups and subgroups based on their responses to different culture conditions. Antimicrobial antagonism activity for some of the actinomycetes strains was dependent on culture conditions and development of aerial mycelia under extreme conditions.

Conclusion: We identified several interesting candidate extracts with putative antimicrobial activities against several strains of drug resistant pathogens. Our research of the actinomycetes' ability to produce antibiotics in the near-natural conditions provides a great opportunity to assess their biodiversity and distribution in the Central Asian region and to develop new methodological approaches to the screening of new antimicrobial agents.

Keywords: Actinomycetes; Antibiotic Resistance; Antibiotics; Extremophiles; Natural Products; Pathogens.

PubMed Disclaimer

Figures

Figure 1A
Figure 1A
Map of field trips collecting soil samples
Figure 1B
Figure 1B
The unusual ecosystem of Northern Kazakhstan. In Northern Kazakhstan (Kustanai region), samples were collected from the soils of the steppe and forest zones, sor solonchaks (non-perennial salts lakes in the area of Aman-Karagai forest), solods, solonets soils (steppe and meadow), rhizospheres of plants from halophytic meadows, and muds from the salt lakes.
Figure 1C
Figure 1C
The unusual ecosystem of Southern Kazakhstan. In Southern Kazakhstan (Almaty region), samples were collected from the soils of the arid zone, typical meadows and sor solonchaks, salinized takyrs, takyr-like salinized soils, and rhizospheres of the arid zone plants.
Figure 2
Figure 2
The classification of actinomycetes from extreme ecosystems into groups and subgroups
Figure 2
Figure 2
The classification of actinomycetes from extreme ecosystems into groups and subgroups
Figure 2
Figure 2
The classification of actinomycetes from extreme ecosystems into groups and subgroups

Similar articles

Cited by

References

    1. Singer RS, Finch R, Wegener HC, Bywater R, Walters J, Lipsitch M. Antibiotic resistance--the interplay between antibiotic use in animals and human beings. The Lancet Infectious diseases. 2003;3(1):47–51. - PubMed
    1. Talbot GH, Bradley J, Edwards JE, Jr, Gilbert D, Scheld M, Bartlett JG. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2006;42(5):657–668. - PubMed
    1. Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. Journal of natural products. 2007;70(3):461–477. - PubMed
    1. Tobias Kieser MJB, Buttner Mark J, Chater Keith F, Hopwood David A. Practical Streptomyces Genetics. [Accessed 11 Jul, 2018]. https://www.jic.ac.uk/science/molmicro/Strepmanual/Manual.htm.
    1. Demain AL. Pharmaceutically active secondary metabolites of microorganisms. Applied microbiology and biotechnology. 1999;52(4):455–463. - PubMed

LinkOut - more resources